Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Viridian Therapeutics Inc. buy skyrockerZoe

Start price
€14.50
29.05.21 / 0%
Target price
-
29.05.22
Performance (%)
-22.76%
End price
€11.20
30.05.22
Summary
This prediction ended on 30.05.22 with a price of €11.20. The prediction for Viridian Therapeutics Inc. disappointed with a performance of -22.76%. This prediction was marked as speculative and is excluded from skyrockerZoe's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Viridian Therapeutics Inc. - - -
iShares Core DAX® -1.785% -1.250% 11.664%
iShares Nasdaq 100 -2.154% 0.300% 37.531%
iShares Nikkei 225® -4.028% -3.746% 17.142%
iShares S&P 500 -1.969% 0.307% 25.617%

According to skyrockerZoe what are the pros and cons of Viridian Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by skyrockerZoe for this prediction

In the thread Viridian Therapeutics Inc. diskutieren

Buy Viridian Therapeutics Inc.

In the thread Trading Viridian Therapeutics Inc.
Prediction Buy
Perf. (%) -22.76%
Target price
Change
Ends at 29.05.22

Die von skyrockerZoe gewählte maximale Laufzeit wurde überschritten